Hiroomi Tada

Hiroomi Tada has served as our Chief Medical Officer since November 2020. Prior to joining Tyra, Hiroomi served as Chief Medical Officer at Notable Labs, Inc., a personalized precision oncology company. Prior to Notable Labs, he served in various roles at Incyte Corp. including Vice President of Translational Sciences for Target Therapies. Hiroomi has also served in various clinical development roles at GlaxoSmithKline and AstraZeneca. Prior to joining the pharmaceutical industry, Hiroomi held faculty appointments as Assistant Professor of Surgery at the University of Massachusetts Medical School and Temple University School of Medicine. Hiroomi holds a B.A. from Haverford College, a Ph.D. in Biochemistry and Molecular Biology from Thomas Jefferson University and an M.D. from Jefferson Medical College and completed his fellowship in Surgical Oncology at the University of Texas, MD Anderson Cancer Center.